NCT01522742View on ClinicalTrials.gov

Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study

TerminatedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Psoriasis
Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Immunex Corporation
All Listed Sponsors
collaborator

Immunex Corporation

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT01522742 - Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study | Biotech Hunter | Biotech Hunter